Zobrazeno 1 - 10
of 163
pro vyhledávání: '"PANAGIOTA ECONOMOPOULOU"'
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/1f30f6be773b45f88d757136c097d811
Autor:
Giannis Mountzios, MD, PhD, David Planchard, MD, PhD, Giulio Metro, MD, PhD, Dora Tsiouda, Arsela Prelaj, MD, Sofia Lampaki, MD, PhD, Walid Shalata, MD, Mariona Riudavets, Petros Christopoulos, MD, PhD, Nicolas Girard, MD, PhD, Víctor Albarrán-Artahona, Rosario Garcia Campelo, MD, PhD, Konstantinos Samitas, MD, PhD, Giuseppe Luigi Banna, MD, Ioannis Boukovinas, MD, PhD, Abed Agbarya, MD, PhD, Anna Koumarianou, MD, Eleni-Isidora Perdikouri, Paris Kosmidis, Helena Linardou, MD, PhD, David Mauri, MD, PhD, Dimitrios Mavroudis, MD, PhD, Ilias Athanasiadis, MD, PhD, Haralambos Kalofonos, Nikolaos Xenidis, MD, PhD, Ippokratis Korantzis, MD, Alexandros Ardavanis, Grigorios Rallis, MD, Achille Bottiglieri, Konstantinos Efthymiadis, MD, Georgios Oikonomopoulos, MD, Alexandros Kokkalis, MD, Emmanouil Saloustros, MD, PhD, Nikolaos Tsoukalas, MD, Dimitra Bartzi, MD, Panagiota Economopoulou, Amanda Psyrri, MD, PhD, Martin Reck, Giuseppe Lo Russo, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 1, Pp 100433- (2023)
Introduction: Real-world evidence regarding molecular epidemiology and management patterns of patients with EGFR exon-20 mutated, advanced NSCLC outside the context of clinical trials is lacking. Methods: We created a European registry for patients w
Externí odkaz:
https://doaj.org/article/1da16fe8f3c8428eb04732eb21d2f835
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/4f8aeba61590463cb8255093734aba68
Publikováno v:
Biomedicines, Vol 11, Iss 6, p 1768 (2023)
The approval of monoclonal antibodies against programmed death-ligand 1 (PD-L1) and programmed cell death protein (PD1) has changed the landscape of cancer treatment. To date, many immune checkpoint inhibitors (ICIs) have been approved by the FDA for
Externí odkaz:
https://doaj.org/article/4370154b3816457fa9f776f941ca1895
Autor:
Panagiota Economopoulou, Athena Chrysikopoulou, Kalliroi Goula, Ilectra Papiri, Amanda Psyrri, Ioannis Kotsantis, Nikolaos Arkadopoulos, Nikolaos V. Michalopoulos
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 3, Pp 1281-1284 (2020)
Breast metastasis originating from non-mammary tumors is an uncommon event accounting for 0.5–6.6% of all breast neoplasms. The primary malignancies that reportedly metastasize to the breast most frequently are hematologic malignancies, such as leu
Externí odkaz:
https://doaj.org/article/ff4c421470844e749367cb7ea40f4c22
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/cd21d56d67b841d9af289e2a4cc96b5b
Autor:
Nektarios Koufopoulos, Ioannis S. Pateras, Alina Roxana Gouloumis, Argyro Ioanna Ieronimaki, Andriani Zacharatou, Aris Spathis, Danai Leventakou, Panagiota Economopoulou, Amanda Psyrri, Nikolaos Arkadopoulos, Ioannis G. Panayiotides
Publikováno v:
Diagnostics, Vol 12, Iss 11, p 2658 (2022)
Invasive lobular carcinoma is the most common special breast carcinoma subtype, with unique morphological (discohesive cells, single-cell files, targetoid pattern) and immunohistochemical (loss of E-cadherin and β-catenin staining) features. Moreove
Externí odkaz:
https://doaj.org/article/fe8f728f11554d90ac8ab94a140da835
Autor:
Panagiota Economopoulou, Vassiliki Kotoula, Georgia-Angeliki Koliou, Kyriaki Papadopoulou, Christos Christodoulou, George Pentheroudakis, Georgios Lazaridis, Petroula Arapantoni-Dadioti, Angelos Koutras, Dimitris Bafaloukos, Pavlos Papakostas, Helen Patsea, Kitty Pavlakis, Dimitrios Pectasides, Athanasios Kotsakis, Evangelia Razis, Gerasimos Aravantinos, Epaminondas Samantas, Konstantine T. Kalogeras, Theofanis Economopoulos, Amanta Psyrri, George Fountzilas
Publikováno v:
Translational Oncology, Vol 12, Iss 5, Pp 739-748 (2019)
BACKGROUND: Src, CDKN1B, and JAK2 play a crucial role in the coordination of cell signaling pathways. In the present study, we aim to investigate the prognostic significance of these biomarkers in HER2-positive metastatic breast cancer (MBC) patients
Externí odkaz:
https://doaj.org/article/7b5f5221fc6f4eb8b5d945f2e4ffafcf
Autor:
Amanda Psyrri, Evangelos Giotakis, Panagiota Economopoulou, Athina Kladi-Skandali, Areti Strati, George Koytsodontis, Efthymios Kirodimos, Pavlos Maragoudakis, Eleni Gagari, Eirini Maratou, George Dimitriadis, Ioannis Kotsantis, Elena Vagia, Maria Anastasiou, Maria Gkotzamanidou, George Kavourakis, Evi Lianidou
Publikováno v:
ESMO Open, Vol 5, Iss 3 (2020)
Background We sought to determine the prognostic role of indoleamine 2,3-dioxygenase 1 (IDO1) by evaluating IDO1 expression in circulating tumour cells (CTCs) at baseline and after completion of chemoradiotherapy in patients with locally advanced (LA
Externí odkaz:
https://doaj.org/article/3a81293b71054edaaf2f6ba9680f471f
Autor:
Panagiota Economopoulou, Anastasios Pantazopoulos, Aris Spathis, Ioannis Kotsantis, Anastasios Kyriazoglou, George Kavourakis, Roubini Zakopoulou, Ioannis Chatzidakis, Maria Anastasiou, Maria Prevezanou, Carlo Resteghini, Lisa Licitra, Cristiana Bergamini, Elena Colombo, Francesca Caspani, Nerina Denaro, Stefania Vecchio, Pierluigi Bonomo, Maria Cossu Rocca, Federica Bertolini, Daris Ferrari, Amanda Psyrri, Paolo Bossi
Publikováno v:
Cells, Vol 11, Iss 1, p 32 (2021)
Background: nasopharyngeal carcinoma (NPC) is a complex disease entity that mainly predominates in endemic regions. Real-world data with immunotherapy from nonendemic regions are limited. Methods: we collected data from patients with recurrent/metast
Externí odkaz:
https://doaj.org/article/07b0958aff5f4503989c97d0a1e5d398